Status:
COMPLETED
REal-worLd vAlidaTION of PhotoPlehtysmoGraphy (for Atrial Fibrillation Detection)
Lead Sponsor:
Ziekenhuis Oost-Limburg
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Mobile health solutions for rhythm monitoring (e.g. atrial fibrillation detection) using photoplethysmography (PPG) technology on a smartphone have been developed. This study validates the performance...
Eligibility Criteria
Inclusion
- Subject is scheduled for an ablation procedure for AF, at least 4 weeks after the inclusion.
- Subject provides informed consent.
- Subject understands and agrees to comply with planned study procedures.
- Subject is able to perform measurements of the heart rhythm using the FibriCheck application at home.
Exclusion
- Insufficient cognitive or comprehensive level of Dutch to participate to the trial.
- No access to a smartphone or unable to perform FibriCheck measurements at home.
- Pacemaker.
Key Trial Info
Start Date :
December 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06028893
Start Date
December 1 2022
End Date
August 31 2023
Last Update
October 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ziekenhuis Oost-Limburg
Genk, Limburg, Belgium, 3600